Sibutramine hydrochloride monohydrate

被引:17
|
作者
Oliveira, P. R. [1 ]
Stulzer, H. K. [2 ]
Bernardi, L. S. [1 ]
Borgmann, S. H. M. [1 ]
Cardoso, S. G. [1 ]
Silva, M. A. S. [1 ]
机构
[1] Univ Fed Santa Catarina, Hlth Sci Ctr, Dept Pharmaceut Sci, Qual Control Lab, BR-88040900 Florianopolis, SC, Brazil
[2] Univ Estadual Ponta Grossa, Dept Pharmaceut Sci, Qual Control Lab, BR-84010919 Ponta Grossa, PR, Brazil
关键词
Sibutramine; Thermal characterization; Kinetic studies; Compatibility studies; SOLID DOSAGE FORMS; THERMAL-ANALYSIS; NONISOTHERMAL CONDITIONS; DECOMPOSITION KINETICS; BINARY-MIXTURES; EXCIPIENTS; COMPATIBILITY; DSC; FORMULATIONS; BEHAVIOR;
D O I
10.1007/s10973-009-0200-7
中图分类号
O414.1 [热力学];
学科分类号
摘要
In the present work, the thermal decomposition of sibutramine hydrochloride monohydrate (SBT) (an appetite suppressant agent) was studied using differential scanning calorimetry (DSC) and thermogravimetry/derivative thermogravimetry (TG/DTG). Solid-state characterization was carried out by diffuse reflectance infrared fourier transform spectroscopy (DRIFT), scanning electron microscopy (SEM) and X-ray powder diffraction (XRPD). Isothermal and non-isothermal methods were employed to determine the kinetic data of decomposition process. From isothermal experiments, activation energy (Ea) can be obtained from slope of ln t versus 1/T, and the value obtained was 96.06 and 101.43 kJ mol(-1) in N(2) and air atmospheres, respectively. For non-isothermal method Ea can be obtained from plot of logarithms of heating rates, as a function of inverse of temperature, resulting in a value of 96.56 and 98.22 kJ mol(-1) in N(2) and air atmospheres, respectively. The compatibilities of several commonly used pharmaceutical excipients (microcrystalline cellulose, magnesium stearate, colloidal silicon dioxide, lactose monohydrate) and empty hard-gelatin capsules with SBT were evaluated using DSC. The 1:1 physical mixtures of these excipients with SBT showed physical interaction of the drug with magnesium stearate. On the other hand, DRIFT results did not evidence any chemical modifications.
引用
收藏
页码:277 / 282
页数:6
相关论文
共 50 条
  • [2] Design and Evaluation of Microcapsules of Sibutramine Hydrochloride Monohydrate
    Gupta, B. K.
    Chakraborty, M.
    Pal, R. N.
    Debnath, R.
    Mazumder, R.
    Marry, T.
    ASIAN JOURNAL OF CHEMISTRY, 2010, 22 (05) : 3917 - 3922
  • [5] Treatment of fibromyalgia with sibutramine hydrochloride monohydrate: comment on the article by Goldenberg et al
    Palangio, M
    Flores, JA
    Joyal, SV
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : 2545 - 2546
  • [6] Comparative Study on Dissolution Profiles of Sibutramine Hydrochloride Monohydrate from Commercial Capsules
    Maluf, Daniela F.
    Farago, Paulo V.
    Barreira, Sandra M. W.
    Pontarolo, Roberto
    LATIN AMERICAN JOURNAL OF PHARMACY, 2009, 28 (05): : 723 - 727
  • [7] Treatment of fibromyalgia with sibutramine hydrochloride monohydrate: comment on the article by Goldenberg et al - Reply
    Goldenberg, D
    Sandhu, T
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : 2546 - 2546
  • [8] Validation of an analytical method for determination of sibutramine hydrochloride monohydrate in capsules by Uv-Vis spectrophotometry
    Maluf, Daniela F.
    Farago, Paulo V.
    Barreira, Sandra M. W.
    Pedroso, Carlos F.
    Pontarolo, Roberto
    LATIN AMERICAN JOURNAL OF PHARMACY, 2007, 26 (06): : 909 - 912
  • [9] STRUCTURE OF CEPHALORIDINE HYDROCHLORIDE MONOHYDRATE
    SWEET, RM
    DAHL, LF
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1969, 34 (01) : 14 - &
  • [10] Dehydration of detomidine hydrochloride monohydrate
    Veldre, K.
    Actins, A.
    Jaunbergs, J.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 44 (03) : 273 - 280